These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 35586986)
21. An update on host immunity correlates and prospects of re-infection in COVID-19. Negi N; Maurya SP; Singh R; Das BK Int Rev Immunol; 2022; 41(4):367-392. PubMed ID: 34961403 [TBL] [Abstract][Full Text] [Related]
22. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection. Gallais F; Gantner P; Bruel T; Velay A; Planas D; Wendling MJ; Bayer S; Solis M; Laugel E; Reix N; Schneider A; Glady L; Panaget B; Collongues N; Partisani M; Lessinger JM; Fontanet A; Rey D; Hansmann Y; Kling-Pillitteri L; Schwartz O; De Sèze J; Meyer N; Gonzalez M; Schmidt-Mutter C; Fafi-Kremer S EBioMedicine; 2021 Sep; 71():103561. PubMed ID: 34455390 [TBL] [Abstract][Full Text] [Related]
23. A longitudinal study on SARS-CoV-2 seroconversion, reinfection and neutralisation spanning several variant waves and vaccination campaigns, Heinsberg, Germany, April 2020 to November 2022. Schulte B; Richter E; Büning A; Baum M; Breuer A; Zorn J; König J; Geiger M; Eschbach-Bludau M; Heuser J; Zölzer D; Korencak M; Hollstein R; Beins E; Emmert D; Aldabbagh S; Eis-Hübinger AM; Streeck H Euro Surveill; 2024 Jun; 29(26):. PubMed ID: 38940003 [TBL] [Abstract][Full Text] [Related]
24. COVID-19 reinfection: the role of natural immunity, vaccines, and variants. Sciscent BY; Eisele CD; Ho L; King SD; Jain R; Golamari RR J Community Hosp Intern Med Perspect; 2021; 11(6):733-739. PubMed ID: 34804382 [TBL] [Abstract][Full Text] [Related]
32. Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February 2020 to February 2022. Vicentini M; Venturelli F; Mancuso P; Bisaccia E; Zerbini A; Massari M; Cossarizza A; De Biasi S; Pezzotti P; Bedeschi E; Giorgi Rossi P; ; Euro Surveill; 2023 Mar; 28(13):. PubMed ID: 36995374 [TBL] [Abstract][Full Text] [Related]
33. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections and Reinfections Among Fully Vaccinated and Unvaccinated University Athletes-15 States, January-November 2021. Good MK; Czarnik M; Harmon KG; Aukerman D; O'Neal CS; Day C; Goerl K; Sifre K; Fink S; Riggs MA Clin Infect Dis; 2022 Oct; 75(Suppl 2):S236-S242. PubMed ID: 35771661 [TBL] [Abstract][Full Text] [Related]
34. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies. Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184 [TBL] [Abstract][Full Text] [Related]
35. Clinical Spectrum of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Protection From Symptomatic Reinfection. Maier HE; Kuan G; Saborio S; Carrillo FAB; Plazaola M; Barilla C; Sanchez N; Lopez R; Smith M; Kubale J; Ojeda S; Zuniga-Moya JC; Carlson B; Lopez B; Gajewski AM; Chowdhury M; Harris E; Balmaseda A; Gordon A Clin Infect Dis; 2022 Aug; 75(1):e257-e266. PubMed ID: 34411230 [TBL] [Abstract][Full Text] [Related]
36. Reduced Odds of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Vaccination Among New York City Adults, July 2021-November 2021. Levin-Rector A; Firestein L; McGibbon E; Sell J; Lim S; Lee EH; Weiss D; Geevarughese A; Zucker JR; Greene SK Clin Infect Dis; 2023 Feb; 76(3):e469-e476. PubMed ID: 35594552 [TBL] [Abstract][Full Text] [Related]
37. Protective Immunity after Natural Infection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) - Kentucky, USA, 2020. Spicer KB; Glick C; Cavanaugh AM; Thoroughman D Int J Infect Dis; 2022 Jan; 114():21-28. PubMed ID: 34649001 [TBL] [Abstract][Full Text] [Related]
38. A Saliva-Based Serological and Behavioral Analysis of SARS-CoV-2 Antibody Prevalence in Howard County, Maryland. Brown AC; Koshute PT; Cowley HP; Robinette MS; Gravelyn SR; Patel SV; Ju EY; Frommer CT; Zambidis AE; Schneider EJ; Zhao MY; Mugo BK; Clarke W; Kruczynski K; Pisanic N; Heaney CD; Colella TA Microbiol Spectr; 2023 Aug; 11(4):e0276522. PubMed ID: 37289070 [TBL] [Abstract][Full Text] [Related]
39. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study. Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536 [TBL] [Abstract][Full Text] [Related]
40. Population-Weighted Seroprevalence From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Vaccination, and Hybrid Immunity Among US Blood Donations From January to December 2021. Busch MP; Stramer SL; Stone M; Yu EA; Grebe E; Notari E; Saa P; Ferg R; Manrique IM; Weil N; Fink RV; Levy ME; Green V; Cyrus S; Williamson PC; Haynes J; Groves J; Krysztof D; Custer B; Kleinman S; Biggerstaff BJ; Opsomer JD; Jones JM Clin Infect Dis; 2022 Oct; 75(Suppl 2):S254-S263. PubMed ID: 35684973 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]